Applied DNA Sciences (APDN) Misses Q3 EPS by 5c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Applied DNA Reports Fiscal Third Quarter 2018 Financial Results
August 13, 2018 4:05 PM EDT
Company to Hold Conference Call and Webcast Today,
Monday, August 13, 2018 at 4:30 PM EST-
STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the "Company"), announced financial results for the fiscal 2018 third quarter ended June 30, 2018.
Commenting on Applied DNAs results for the fiscal third quarter, Dr. James A. Hayward, president and CEO, stated, Results for the quarter did not fulfill our expectations for recognized revenue due to the shipping of an initial cotton DNA order under extended payment terms.... More
